However, they're different classes of drugs. Any over-the-counter drugs you can buy come in two basic classes. Those classes are:. Ibuprofen is a drug that acts directly at the site of your pain. Paracetamol is a drug that acts in your central nervous system.
There are several other differences between the two drugs as well. Most people are safe to take paracetamol. This includes women who are breastfeeding and pregnant. It's a popular drug because it doesn't react to most other medications. This makes it a popular choice for people on blood thinning medications. Some people should avoid taking this drug. At the very least, it's a good idea to talk to your doctor before you take it. People who want to take include:.
An adult will usually take one mg tablet every four to six hours. You should only take mg in a 24 hour period. You want to wait at least four hours between doses. Also, it can take up to an hour to work. Children can also take Paracetamol. The correct amount goes by weight. It's usually 15 mg for every kilogram.
So, if your child weighs 15 kilograms, the correct dosage would be mg every four hours. Don't double up your dose if you don't get immediate relief. Also, don't take more than the recommended amount in a 24 hour period.
It is possible to overdose on this drug. Side effects of taking this drug are rare. Although the onset of action of i. This was, however in healthy, fasted individuals with presumed normal gastric emptying, undergoing daycase surgery, and results may not be readily extrapolated to other patient groups.
The Medicines and Healthcare products Regulatory Agency MHRA licensed dose of paracetamol is the same for all routes of administration in adults over 50 kg i. Despite its high lipid solubility and low protein binding, a weight-adjusted dosing regime has never been endorsed.
However, in view of the pharmacokinetic data of paracetamol, a case has been made for a single loading dose of 2 g, followed by 4—6 hourly 1 g doses, and this has found its way into clinical practice over recent years.
Studies comparing 2 g with 1 g loading doses for postoperative analgesia in otherwise healthy adult patients have demonstrated lower pain scores and greater duration of effective pain relief with no increase in side-effects or markers of toxicity. In the UK, there have been seven reports of overdose in infants and neonates. In most of these cases, a fold overdose was reported, most probably due to confusion between doses calculated in milligrams vs millilitres.
Oral paracetamol is absorbed, mainly from the small bowel, by passive transport, and has high, though variable, bioavailability. It is metabolized in the liver, predominantly by glucuronidation and sulphation to non-toxic conjugates, but a small amount is also oxidised via the cytochrome P enzyme system to form the highly toxic metabolite, N -acetyl- p -benzo-quinone imine NAPQI.
Under normal conditions, NAPQI is detoxified by conjugation with glutathione to form cysteine and mercapturatic acid conjugates, which are then renally excreted. However, when there is insufficient glutathione e. Thus a CYP-2D6 ultra-rapid and extensive metabolizer is at higher risk of developing toxicity than a slow metabolizer. Although the product information does not recommend any dose adjustment in the elderly, as pharmacokinetics of paracetamol are not specifically modified, glutathione stores may be low in certain patient groups and conditions, including the elderly, infants, and in starvation or malabsorption, etc.
Whilst this does not preclude the use of paracetamol, the interval between doses should be a minimum of 6 h. Paracetamol is safe for use in pregnancy and lactation, with only a negligible amount of the drug reaching breast milk. Interestingly, the total clearance of paracetamol has been demonstrated to be higher in women at delivery including by Caesarean section compared with 10—15 weeks postpartum, which itself was significantly lower than in the normal healthy volunteer population data.
The increased total paracetamol clearance at delivery is attributed to a disproportionate increase in glucuronidation clearance and a proportional increase in both its oxidation clearance and of unchanged paracetamol. Interaction with a variety of other drugs may occur, and warrant caution in co-administration. For example, concomitant intake of enzyme-inducing substances, such as carbamazepine, phenytoin, or barbiturates, as well as chronic alcohol excess, may increase NAPQI production and the risk of paracetamol toxicity.
Concurrent use with isoniazid also increases the risk of toxicity, though as an enzyme inhibitor, the mechanism is not entirely clear. Concomitant use of paracetamol 4 g per day for at least 4 days with oral anticoagulants may lead to slight variations in INR values. Increased monitoring of INR should be conducted during the period of concomitant use as well as for 1 week after paracetamol treatment has been discontinued Table 2.
However, usage within the therapeutic range, particularly frequent regular use, can also impact on other organ systems, with effects that are less widely acknowledged. Paracetamol overdose is the most common and predictable cause, but, in certain individuals, hepatotoxicity may occur with doses within the therapeutic range. This may be secondary to deficiencies in glutathione, because of inadequate nutrition, P enzyme induction by chronic alcohol excess, or concomitant use of other drugs.
Paracetamol has, in fact, been shown to be well tolerated in hepatocellular insufficiency and even cirrhosis within the normal recommended dose range, albeit cautiously. In general, paracetamol is thought to have only minor effects on renal function, of no clinical relevance in the vast majority of patients. Rare effects have included acute renal failure, acute tubular necrosis, and interstitial nephritis, but these are usually observed after either acute overdose, chronic abuse often with multiple analgesics , or in association with paracetamol-related hepatotoxicity; that said, acute tubular necrosis has been observed as an isolated finding in rare cases.
There has been equivocal data regarding whether moderate to long-term use may increase the risk of end-stage renal disease. The mechanism of damage is thought, yet again, to involve the depletion of glutathione—a known anti-oxidant, rendering renal cells particularly sensitive to oxidative damage. Optimizing hydration and nutrition status is therefore of specific relevance in those receiving regular paracetamol. Paracetamol can be associated with non-specific gastrointestinal symptoms, such as nausea and vomiting, dyspepsia, abdominal pain, and bloating.
These effects, however, were mostly abdominal pain and some nausea, and led to no further complications. Rarely, cases of acute pancreatitis have been reported, and one study has suggested that acetaminophen may precipitate acute biliary pain and cholestasis, possibly related to inhibition of prostaglandin and alterations in the regulation of the sphincter of Oddi.
Although also rare, hypotension is a recognized adverse effect, listed in the product information of paracetamol. The limited evidence on the subject would suggest that adults and neonates in a critical care setting, who are either febrile or have pre-existing low blood pressure, may have increased susceptibility to a period of hypotension after either enteral or i. Whilst often only modest and brief, a proportion of these hypotensive episodes did require supportive intervention, although no long-term sequelae were reported.
In adult patients, the hypotension was associated with increased skin blood flow, consistent with its antipyretic action; these effects were not demonstrated in healthy afebrile volunteers, or in elective surgical patients when given paracetamol perioperatively. Conversely, regular use of oral paracetamol has been linked with a raised blood pressure.
Whilst much of these data come from retrospective observational studies, results from two small randomized, placebo-controlled crossover trials conducted in patients with known coronary artery disease or treated hypertension suggest that after as little as 2 weeks of paracetamol at submaximal doses of 1 g three times a day, heart rate and blood pressure may show statistically, though perhaps not clinically, significant rises.
Although most certainly not an NSAID, paracetamol itself may be causally linked with the development of asthma. There has been mounting evidence since of an association between asthma and paracetamol usage, so strong that it is thought by some to have contributed to much of the dramatic increase in childhood asthma over the past 30 years.
The product information for some commercial preparations of paracetamol itself include in their list of possible adverse effects, difficulty breathing, and bronchospasm in patients having a tendency of analgesic asthma. Aside from its role in detoxifiying paracetamol in the liver, glutathione is a pulmonary antioxidant, which may limit airway inflammation in asthma.
Consistent with findings in animal and in vitro studies that paracetamol may deplete the lung of glutathione, a plethora of, largely epidemiological, data are strongly suggestive that frequent paracetamol usage may be a direct risk factor for wheezing, rhinitis, and asthma morbidity in adults and children.
However, there are many anecdotal reports of euphoria or sleepiness particularly in children and the elderly—groups in which metabolism may be reduced , after paracetamol, even in the absence of pain or pyrexia.
However, the mechanism of action of paracetamol remains to be determined; pathways gaining credence include the serotonergic and endocannabinoid systems, both of which are intrinsically involved in consciousness and cognitive function. In the future, a better insight into the mechanism of action of paracetamol may be gained from a fuller understanding of the cyclooxygenase enzymes.
In the meantime, paracetamol may find applications in other therapeutic areas, such as the prevention of atherosclerosis via a potential antioxidant activity. In summary, although it is more than a century since the first clinical use of paracetamol, it continues to be a first-line therapy of choice in adults and children with fever and pain. In addition, current research suggests that paracetamol may have a much broader clinical utility in years to come.
Abstract Paracetamol acetaminophen is one of the most widely used of all drugs, with a wealth of experience clearly establishing it as the standard antipyretic and analgesic for mild to moderate pain states.
0コメント